Abstract
The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Animals
-
Anti-HIV Agents / administration & dosage*
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / metabolism
-
Chemistry, Pharmaceutical
-
Delayed-Action Preparations
-
Drug Administration Schedule
-
Drug Carriers*
-
Drug Combinations
-
Drug Compounding
-
HIV Infections / drug therapy*
-
HIV Infections / metabolism
-
HIV Infections / virology
-
HIV-1 / drug effects*
-
HIV-1 / metabolism
-
Humans
-
Nanomedicine*
-
Nanoparticles*
-
Polymers / chemistry*
-
Technology, Pharmaceutical / methods*
Substances
-
Anti-HIV Agents
-
Delayed-Action Preparations
-
Drug Carriers
-
Drug Combinations
-
Polymers